Once a manuscript has been published in ANTICANCER RESEARCH, which is a copyrighted publication, the legal ownership of all published parts of the paper has been transferred from the Author(s) to the journal. Material published in the journal may not be reproduced or published elsewhere without t...
Development of a rat capnoperitoneum phantom to study drug aerosol deposition in the context of anticancer research on peritoneal carcinomatosis D Ghler,A Geldner,R Gritzki,... - 《Scientific Reports》 被引量: 0发表: 2021年 Design, synthesis and in vitro anticancer research of novel tetrandrine...
A wide range of research activities have been carried out so far on benzimidazole and pyridine derivatives to evaluate their Antiviral, Anticancer, Anticonvulsant, Anthelmintic Activity and many promising results are obtained with respect to the anticancer activity. Out of the various ligands used, the...
Journal of Ultrastructure Research 89, 212–222 (1984). 34. Goldman, A. et al. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy- induced phenotypic transition. Nature Communications 6, 6139 (2015). Acknowledgements This work was financially ...
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/23/prepub Download references Acknowledgements The study was supported by the Commission for Higher Education, Ministry of Education of Thailand (RG) and the National Research University Proje...
KR Choudhary,SR Thrigulla,MS Gundeti,... - 《Ayu An International Quarterly Journal of Research in Ayurveda》 被引量: 0发表: 2023年 加载更多来源期刊 The Scientific World Journal,2013,(2013-5-12) 研究点推荐 Anticancer Antituberculosis 引用走势 2014 被引量:10 站内活动 ...
Conclusion Global bsAbs research increased rapidly during the 1997 to 2020 period. The developed countries in America and Europe are leading the trend of bsAbs research. Anticancer bsAbs clinical research in China is booming and chasing after the world trend. 展开 关键词: Bispecific antibody Bs...
This paper reported the capacity for ERBB3 signalling to be upregulated to compensate for inhibition of other Erbb family members. Article CAS PubMed PubMed Central Google Scholar Engelman, J. A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 ...
are supported by a Mantle Cell Lymphoma Research Initiative grant from the Leukemia and Lymphoma Society. S.C.-K. is further supported by a P01 grant (no. CA214274) from the National Institutes of Health/National Cancer Institute. L.G. is further supported by a Breakthrough Level 2 grant...
paper.pet2008.cn 6. The invention relates to a tumor targeting macromolecule controlled release anticancer drug and a preparation method and uses thereof. 本发明涉及一类肿瘤靶向性大分子控制释放抗癌药物及制备方法和用途。 ip.com 7. Yet there are many anticancer drugs that do not always cause these...